Optical Coherence Tomography for Pancreatic Cancer

Phase-Based Progress Estimates
Ohio State University Comprehensive Cancer Center, Columbus, OHPancreatic Cancer+1 MoreOptical Coherence Tomography - Procedure
All Sexes
What conditions do you have?

Study Summary

This trialtests a new imaging tech to detect small pancreatic cancer in people with the disease. It may help accurately identify cancer in resected tissue.

Eligible Conditions
  • Pancreatic Cancer
  • Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Up to 3 years

Up to 3 years
Measure accuracy of using OCT to diagnose pancreatic cancer and compare with histology.

Trial Safety

Safety Progress

1 of 3

Similar Trials

Trial Design

1 Treatment Group

Diagnostic (resection, OCT)
1 of 1

Experimental Treatment

75 Total Participants · 1 Treatment Group

Primary Treatment: Optical Coherence Tomography · No Placebo Group · N/A

Diagnostic (resection, OCT)Experimental Group · 3 Interventions: Optical Coherence Tomography, Therapeutic Conventional Surgery, Laboratory Evaluation · Intervention Types: Procedure, Procedure, DiagnosticTest
First Studied
Drug Approval Stage
How many patients have taken this drug
Optical Coherence Tomography
Completed Phase 2
Therapeutic Conventional Surgery
Completed Phase 3

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 years

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,156 Previous Clinical Trials
41,163,531 Total Patients Enrolled
Ohio State University Comprehensive Cancer CenterLead Sponsor
290 Previous Clinical Trials
286,064 Total Patients Enrolled
Mary Dillhoff, MDPrincipal Investigator - Ohio State University Comprehensive Cancer Center
Ohio State University Hospital - Wexner Medical Center, Richard M. Ross Heart Hospital
University Of Cincinnati College Of Medicine (Medical School)
1 Previous Clinical Trials
7 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are an adult with pancreatic cancer or a type of pancreatic cyst called IPMN.

Frequently Asked Questions

How many participants is the clinical trial currently accommodating?

"Affirmative. Clinicaltrials.gov presents evidence that this experiment is currently attempting to recruit participants, with the first post being on March 26th 2019 and the latest edit occurring on November 22nd 2022. In total, 75 individuals are needed from one medical facility." - Anonymous Online Contributor

Unverified Answer

Is this research initiative currently seeking participants?

"Clinicaltrials.gov notes that this study is accepting participants, having been first published on March 26th 2019 and most recently revised on November 22nd 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.